IGHE and allergic disease: Recent studies have shown that blocking IgE can reduce the susceptibility to respiratory virus infections by enhancing IFN-α signal in plasmacytoid dendritic cells and that allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergic reactions [20–22].